Diffusion of information throughout the host interactome reveals gene expression variations in network proximity to target proteins of hepatitis C virus

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Mosca, Ettore ^a   Alfieri, Roberta ^a   Milanesi, Luciano ^a  

^a INSTITUTE OF BIOMEDICAL TECHNOLOGIES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN;

ARTICLE; CELLULAR STRESS RESPONSE; DYSPLASIA; GENE EXPRESSION; GENETIC VARIABILITY; HEPATITIS C VIRUS; IMMUNE RESPONSE; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MOLECULAR INTERACTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; VIRUS CELL INTERACTION; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; HEPACIVIRUS; HEPATITIS C; HOST PATHOGEN INTERACTION; HUMAN; LIVER TUMOR; METABOLISM; PATHOGENICITY; PATHOLOGY; VIROLOGY;

HEPATITIS C VIRUS;

CARCINOMA, HEPATOCELLULAR; GENE EXPRESSION REGULATION, VIRAL; GENE REGULATORY NETWORKS; HEPACIVIRUS; HEPATITIS C; HEPATOCYTES; HOST-PATHOGEN INTERACTIONS; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; PROTEIN INTERACTION MAPS; VIRAL PROTEINS;

EID: 84914676497     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113660     Document Type: Article

References (68)

1. Arzumanyan A, Reis HM, Feitelson MA (2013) Pathogenic mechanisms in HBV-and HCV-associated hepatocellular carcinoma. Nature Reviews Cancer 13: 123-35.
2. Morgan RL, Baack B, Smith BD, Yartel A, Pitasi M, et al. (2013) Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies. Annals of Internal Medicine 158: 329-37.
3. Zender L, Villanueva A, Tovar V, Sia D, Chiang DY, et al. (2010) Cancer gene discovery in hepatocellular carcinoma. Journal of Hepatology 52: 921-929.
4. Shlomai A, de Jong YP, Rice CM (2014) Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma. Semin Cancer Biol 26C: 78-88.
5. Wang PI, Marcotte EM (2010) It's the machine that matters: Predicting gene function and phenotype from protein networks. J Proteomics 73: 2277-2289.
6. Raphael BJ (2013) Making connections: using networks to stratify human tumors. Nat Methods 10: 1077-1078.
7. Drozdov I, Bornschein J, Wex T, Valeyev NV, Tsoka S, et al. (2012) Functional and topological properties in hepatocellular carcinoma transcriptome. PLoS One 7: e35510.
8. Zheng S, Tansey WP, Hiebert SW, Zhao Z (2011) Integrative network analysis identifies key genes and pathways in the progression of hepatitis C virus induced hepatocellular carcinoma. BMC Med Genomics 4: 62.
9. He B, Zhang H, Shi T (2011) A comprehensive analysis of the dynamic biological networks in HCV induced hepatocarcinogenesis. PLoS One 6: e18516.
10. Mukhopadhyay A, Maulik U (2014) Network-based study reveals potential infection pathways of hepatitis-C leading to various diseases. PLoS One 9: e94029.
11. Gulbahce N, Yan H, Dricot A, Padi M, Byrdsong D, et al. (2012) Viral perturbations of host networks reflect disease etiology. PLoS Comput Biol 8: e1002531.
12. Vanunu O, Magger O, Ruppin E, Shlomi T, Sharan R (2010) Associating genes and protein complexes with disease via network propagation. PLoS Comput Biol 6: e1000641.
13. Hofree M, Shen JP, Carter H, Gross A, Ideker T (2013) Network-based stratification of tumor mutations. Nat Methods 10: 1108-1115.
14. Stokes ME, Barmada MM, Kamboh MI, Visweswaran S (2014). The application of network label propagation to rank biomarkers in genome-wide Alzheimer's data. BMC Genomics 15: 282.
15. Qian Y, Besenbacher S, Mailund T, Schierup MH (2014) Identifying disease associated genes by network propagation. BMC Syst Biol 8: S6.
16. de Chassey B, Navratil V, Tafforeau L, Hiet MS, Aublin-Gex A, et al. (2008) Hepatitis C virus infection protein network. Mol Syst Biol 4: 230.
17. Tripathi LP, Kataoka C, Taguwa S, Moriishi K, Mori Y, et al. (2010) Network based analysis of hepatitis C virus core and NS4B protein interactions. Mol Biosyst 6: 2539-2553.
18. Dolan PT, Zhang C, Khadka S, Arumugaswami V, Vangeloff AD, et al. (2013) Identification and comparative analysis of hepatitis C virus-host cell protein interactions.t. Mol Biosys 9: 3199-3209.
19. Kwofie SK, Schaefer U, Sundararajan VS, Bajic VB, Christoffels A (2011) HCVpro: hepatitis C virus protein interaction database. Infect Genet Evol 11: 1971-1977.
20. Kumar R, Nanduri B (2010) HPIDB-a unified resource for host-pathogen interactions. BMC Bioinformatics. Suppl 6: S16.
21. Hermjakob H, Montecchi-Palazzi L, Lewington C, Mudali S, Kerrien S, et al. (2004) IntAct: an open source molecular interaction database. Nucleic Acids Res 32: D452-D455.
22. Navratil V, de Chassey B, Meyniel L, Delmotte S, Gautier C, et al. (2009) VirHostNet: a knowledge base for the management and the analysis of proteome-wide virus-host interaction networks. Nucleic Acids Res 37: D661-D668.
23. Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M (2013) STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res 41: D808-D815.
24. Matteucci C, Sorrentino R, Bellis L, Ettorre GM, Svicher V, et al. (2014) Detection of high levels of Survivin-immunoglobulin M immune complex in sera from hepatitis C virus infected patients with cirrhosis. Hepatol Res 44: 1008-1018.
25. Jackson MA, Lea I, Rashid A, Peddada SD, Dunnick JK (2006) Genetic alterations in cancer knowledge system: analysis of gene mutations in mouse and human liver and lung tumors. Toxicol Sci 90: 400-418.
26. Gale M Jr, Foy EM (2005) Evasion of intracellular host defence by hepatitis C virus. Nature 436: 939-945.
27. Zhu Z, Wilson AT, Gopalakrishna K, Brown KE, Luxon BA, et al. (2010) Hepatitis C virus core protein enhances Telomerase activity in Huh7 cells. J Med Virol 82: 239-248.
28. Bauer-Mehren A, Bundschus M, Rautschka M, Mayer MA, Sanz F, et al. (2011) Gene-disease network analysis reveals functional modules in mendelian, complex and environmental diseases. PLoS One. 6: e20284.
29. Barrett T, Troup DB, Wilhite SE, Ledoux P, Rudnev D, et al. (2009) NCBI GEO: archive for high-throughput functional genomic data. Nucleic Acids Res 37: D885-D890.
30. Wurmbach E, Chen YB, Khitrov G, Zhang W, Roayaie S, et al. (2007) Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology 45: 938-947.
31. Mas VR, Maluf DG, Archer KJ, Yanek K, Kong X, et al. (2009) Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma. Mol Med 15: 85-94.
32. Rehermann B (2009) Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. J Clin Invest 119: 1745-1754.
33. Mosca E, Milanesi L (2013) Network-based analysis of omics with multi-objective optimization. Mol Biosyst 9: 2971-2980.
34. Steuer RE (1986) Multiple Criteria Optimization: Theory, Computation and Application.y. New York: John Wile. 546 pp.
35. Tran G (2008) The role of hepatitis C virus in the pathogenesis of hepatocellular carcinoma. Bioscience Horizons 1: 167-175.
36. Zhao H, De BP, Das T, Banerjee AK (1996) Inhibition of human parainfluenza virus-3 replication by interferon and human MxA. Virology 220: 330-338.
37. Pramhas S, Homoncik M, Ferenci P, Ferlitsch A, Scherzer T, et al. (2010) von Willebrand factor antigen: a novel on-treatment predictor of response to antiviral therapy in chronic hepatitis C genotypes 1 and 4. Antivir Ther 15: 831-839.
38. Itsui Y, Sakamoto N, Kakinuma S, Nakagawa M, Sekine-Osajima Y, et al. (2009) Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein. Hepatology 50: 1727-1737.
39. Parisi GF, Di Dio G, Franzonello C, Gennaro A, Rotolo N, et al. (2013) Liver disease in cystic fibrosis: an update. Hepat Mon 13: e11215.
40. Chau TK, Marakami S, Kawai B, Nasu K, Kubota T, et al. (2000) Genotype analysis of the CYP2C19 gene in HCV-seropositive patients with cirrhosis and hepatocellular carcinoma. Life Sci 67: 1719-1724.
41. Feranchak AP, Doctor RB, Troetsch M, Brookman K, Johnson SM, et al. (2004) Calcium-dependent regulation of secretion in biliary epithelial cells: the role of apamin-sensitive SK channels. Gastroenterology 127: 903-913.
42. Banerjee A, Ray RB, Ray R (2010) Oncogenic potential of hepatitis C virus proteins. Viruses 2: 2108-2133.
43. Lin SY, Pan HW, Liu SH, Jeng YM, Hu FC, et al. (2008) ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma. Clin Cancer Res 14: 4814-4820.
44. Marshall A, Lukk M, Kutter C, Davies S, Alexander G, et al. (2013) Global gene expression profiling reveals SPINK1 as a potential hepatocellular carcinoma marker. PLoS One 8: e59459.
45. Maass T, Sfakianakis I, Staib F, Krupp M, Galle PR, et al. (2010) Microarray-based gene expression analysis of hepatocellular carcinoma. Curr Genomics 11: 261-268.
46. Eferl R, Wagner EF (2003) AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3: 859-868.
47. Min L, Ji Y, Bakiri L, Qiu Z, Cen J, et al. (2012) Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin. Nat Cell Biol 14: 1203-1211.
48. Bièche I, Asselah T, Laurendeau I, Vidaud D, Degot C, et al. (2005) Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection. Virology 332: 130-144.
49. Behnke MK, Reimers M, Fisher RA (2013) Stem cell and hepatocyte proliferation in hepatitis C cirrhosis and hepatocellular carcinoma: transplant implications. Ann Hepatol 13: 45-53.
50. Chen H, Shen ZY, Xu W, Fan TY, Li J, et al. (2014) Expression of P450 and nuclear receptors in normal and end-stage Chinese livers. World J Gastroenterol 20: 8681-8690.
51. Wei L, Lian B, Zhang Y, Li W, Gu J, et al. (2014) Application of microRNA and mRNA expression profiling on prognostic biomarker discovery for hepatocellular carcinoma. BMC Genomics 15: S13
52. Venkatesan K, Rual JF, Vazquez A, Stelzl U, Lemmens I, et al. (2009) An empirical framework for binary interactome mapping. Nat Methods 6: 83-90.
53. De Las Rivas J, Fontanillo C (2010) Protein-Protein Interactions Essentials: Key Concepts to Building and Analyzing Interactome Networks. PLoS Comput Biol 6: e1000807.
54. Ivanov AA, Khuri FR, Fu H (2013) Targeting protein-protein interactions as an anticancer strategy. Trends Pharmacol Sci 34: 393-400.
55. Milroy LG, Grossmann TN, Hennig S, Brunsveld L, Ottmann C (2014) Modulators of Protein-Protein Interactions. Chem Rev 114: 4695-4748.
56. Zhou D, Bousquet O, Lal TN, Weston J, Scholkopf B (2003) Learning with local and global consistency. In: Thrun S, Saul LK, Schölkopf B, editors. Advances in Neural Information Processing Systems 16. London: The MIT Press.
57. Wilson CL, Miller CJ (2005) Simpleaffy: a BioConductor package for Affymetrix Quality Control and data analysis. Bioinformatics 21: 3683-3685
58. Smyth GK (2005) Limma: linear models for microarray data. In, Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W, Bioinformatics and Computational Biology Solutions Using {R} and Bioconductor. New York: Springer.
59. Kauffmann A, Gentleman R, Huber W (2009) arrayQualityMetrics-a bioconductor package for quality assessment of microarray data. Bioinformatics 25: 415-416.
60. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci 25: 15545-15550.
61. Wang X, Terfve C, Rose JC, Markowetz F (2011) HTSanalyzeR: an R/Bioconductor package for integrated network analysis of high-throughput screens. Bioinformatics 15: 879-880.
62. Xiao Y, Hsiao TH, Suresh U, Chen HI, Wu X, et al. (2014) A novel significance score for gene selection and ranking. Bioinformatics 30: 801-807.
63. Kanehisa M, Goto S (2000) KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res 28: 27-30.
64. Croft D, Mundo AF, Haw R, Milacic M, Weiser J, et al. (2014) The Reactome pathway knowledgebase. Nucleic Acids Res 42: D472-D477.
65. Huang da W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
66. Haw R, Hermjakob H, D'Eustachio P, Stein L (2011) Reactome pathway analysis to enrich biological discovery in proteomics data sets. Proteomics 11: 3598-3613.
67. BiodigitalValley: ProteinQuest, a web based platform for the mining of Medline papers. Available: http://www.proteinquest.com. [Online] 2013.
68. Iorio F, Bosotti R, Scacheri E, Belcastro V, Mithbaokar P, et al. (2010) Discovery of drug mode of action and drug repositioning from transcriptional responses. Proc Natl Acad Sci 107: 14621-14626.